US biotech Kite set to be first to launch one-time cancer gene therapy in Britain – Telegraph.co.uk
Telegraph.co.uk |
US biotech Kite set to be first to launch one-time cancer gene therapy in Britain
Telegraph.co.uk US biotech Kite is expected to be first out of the blocks in Britain to launch a one-time genetic treatment for a type of cancer, in a global market expected to hit $54bn (£41.6bn) in value. The first so-called CAR-T treatment, developed by Swiss giant … |
